RPID Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 20:17):

Stats
Šios dienos apimtis	24 067.00
Vidutinė apimtis	40 826.00
Rinkos kapitalizacija	41.79M
EPS	$0 ( 2024-03-01 )
Kita pelno data	( $-0.290 ) 2024-05-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.800
ATR14	$0.00800 (0.82%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	Wilson John J. Addington	Sell	9 569	Class A Common Stock
2024-03-11	Vezina Victoria	Sell	5 435	Class A Common Stock
2024-03-11	Wirtjes Sean M	Sell	7 454	Class A Common Stock
2024-03-11	Spignesi Robert G. Jr.	Sell	10 323	Class A Common Stock
2024-02-12	Wilson John J. Addington	Sell	5 809	Class A Common Stock

INSIDER POWER
91.52
Last 96 transactions
Buy: 3 823 953 \| Sell: 95 953

Rapid Micro Biosystems, Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
QLGN	0.971
ARQQ	0.97
LYEL	0.967
WISA	0.967
NKTX	0.961
TOPS	0.96
SLNH	0.959
STRC	0.959
GROM	0.958
SWVL	0.958

10 Labiausiai neigiamai susiję koreliacijos
NWFL	-0.958
LRFC	-0.958
PEBK	-0.958
MNKD	-0.955
NECB	-0.946
LUNA	-0.945
IVAC	-0.944
GDNR	-0.941
STAY	-0.939
ALOR	-0.937

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Rapid Micro Biosystems, Koreliacija - Valiuta/Žaliavos

0.27
( neutral )

0.33
( neutral )

0.00
( neutral )

0.21
( neutral )

-0.19
( neutral )

-0.13
( neutral )

Rapid Micro Biosystems, Finansinės ataskaitos

Annual	2023
Pajamos:	$22.52M
Bruto pelnas:	$-5.49M (-24.36 %)
EPS:	$-1.220

FY	2023
Pajamos:	$22.52M
Bruto pelnas:	$-5.49M (-24.36 %)
EPS:	$-1.220

FY	2022
Pajamos:	$17.13M
Bruto pelnas:	$-8.54M (-49.85 %)
EPS:	$-1.430

FY	2021
Pajamos:	$23.23M
Bruto pelnas:	$-7.74M (-33.32 %)
EPS:	$-1.901

Financial Reports:

No articles found.

Rapid Micro Biosystems,

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Realaus laiko atnaujinimai Rapid Micro Biosystems, [RPID]

Upcoming Earnings Alert